药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Mecasermin
Bectumomab
The risk or severity of adverse effects can be increased when Bectumomab is combined with Brentuximab vedotin.
Mecasermin
Epratuzumab
The risk or severity of adverse effects can be increased when Epratuzumab is combined with Brentuximab vedotin.
Mecasermin
Pexelizumab
The risk or severity of adverse effects can be increased when Pexelizumab is combined with Brentuximab vedotin.
Mecasermin
Galiximab
The risk or severity of adverse effects can be increased when Galiximab is combined with Brentuximab vedotin.
Mecasermin
Adenovirus type 7 vaccine live
The risk or severity of infection can be increased when Adenovirus type 7 vaccine live is combined with Brentuximab vedotin.
Mecasermin
Vibrio cholerae CVD 103-HgR strain live antigen
The risk or severity of infection can be increased when Vibrio cholerae CVD 103-HgR strain live antigen is combined with Brentuximab vedotin.
Mecasermin
Human adenovirus e serotype 4 strain cl-68578 antigen
The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Brentuximab vedotin.
Mecasermin
BCG vaccine
The risk or severity of infection can be increased when BCG vaccine is combined with Brentuximab vedotin.
Mecasermin
Bacillus calmette-guerin substrain danish 1331 live antigen
The risk or severity of infection can be increased when Bacillus calmette-guerin substrain danish 1331 live antigen is combined with Brentuximab vedotin.
Mecasermin
Typhoid Vaccine Live
The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Brentuximab vedotin.
Mecasermin
Anthrax vaccine
The risk or severity of infection can be increased when Anthrax vaccine is combined with Brentuximab vedotin.
Mecasermin
Yellow Fever Vaccine
The risk or severity of infection can be increased when Yellow Fever Vaccine is combined with Brentuximab vedotin.
Mecasermin
Bacillus calmette-guerin substrain connaught live antigen
The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Brentuximab vedotin.
Mecasermin
Bacillus calmette-guerin substrain tice live antigen
The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Brentuximab vedotin.
Mecasermin
Varicella Zoster Vaccine (Live/attenuated)
The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Brentuximab vedotin.
Mecasermin
Rubella virus vaccine
The risk or severity of infection can be increased when Rubella virus vaccine is combined with Brentuximab vedotin.
Mecasermin
Pitolisant
The serum concentration of Brentuximab vedotin can be decreased when it is combined with Pitolisant.
Mecasermin
Ocrelizumab
Ocrelizumab may increase the immunosuppressive activities of Brentuximab vedotin.
Mecasermin
Moderna COVID-19 Vaccine
The therapeutic efficacy of Moderna COVID-19 Vaccine can be decreased when used in combination with Brentuximab vedotin.
Mecasermin
Modified vaccinia ankara
The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Brentuximab vedotin.